| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $568.1M | -0.9% |
| Cost of Revenue | $179.9M | -2.8% |
| Gross Profit | $388.2M | -0.0% |
| R&D Expense | $12.1M | -11.2% |
| SG&A Expense | $314.0M | -7.9% |
| Operating Income | $54.0M | +550.6% |
| Pre-tax Income | $25.7M | +152.3% |
| Income Tax | -$1.6M | +70.4% |
| Net Income | $22.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.2M | +23.2% |
| Accounts Receivable | $128.3M | +0.7% |
| Inventory | $82.2M | -11.1% |
| Current Assets | $272.8M | -1.0% |
| Total Assets | $683.6M | -6.1% |
| Current Liabilities | $160.4M | -23.8% |
| Long-term Debt | $279.0M | -9.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.7M | +92.5% |
| Capital Expenditures | $2.6M | +154.7% |
| Investing Cash Flow | -$3.2M | -114.1% |
| Financing Cash Flow | -$62.1M | -13.9% |
| Free Cash Flow | $72.1M | +90.8% |
| +167.8% |
| EPS (Basic) | $0.34 | +165.4% |
| EPS (Diluted) | $0.33 | +163.5% |
| Total Liabilities |
| $455.1M |
| -16.1% |
| Stockholders' Equity | $184.1M | +24.4% |